Alexander Skorokhod
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
TERT promoter mutation subtypes and survival in stage I and II melanoma patients.
Journal: International journal of cancer
Published: April 30, 2018
Variables that influence BRAF mutation probability: A next-generation sequencing, non-interventional investigation of BRAFV600 mutation status in melanoma.
Journal: PloS one
Published: September 07, 2017
Universal BRAF State Detection by the Pyrosequencing®-Based U-BRAF(V⁶⁰⁰) Assay.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 25, 2015
Opening a niche for therapy: local lymphodepletion helps the immune system to fight melanoma.
Journal: The Journal of investigative dermatology
Published: June 14, 2014
Automated universal BRAF state detection within the activation segment in skin metastases by pyrosequencing-based assay U-BRAF(V600).
Journal: PloS one
Published: November 28, 2012
Detection of BRAF V600E mutations in skin metastases of malignant melanoma by monoclonal antibody VE1.
Journal: Journal of the American Academy of Dermatology
Published: January 11, 2012
Real-imaging cDNA-AFLP transcript profiling of pancreatic cancer patients: Egr-1 as a potential key regulator of muscle cachexia.
Journal: BMC cancer
Published: December 19, 2011
RASSF10 promoter hypermethylation is frequent in malignant melanoma of the skin but uncommon in nevus cell nevi.
Journal: The Journal of investigative dermatology
Published: November 25, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026